Fight disinformation: Sign up for the free Mother Jones Daily newsletter and follow the news that matters.


Everything is good news this month. My M-protein level continues to decline, which means the level of cancerous plasma cells in my bone marrow is declining too. I’m still a long way from zero, but heading in the right direction.

At the same time, my immune system rebounded. Last month I was down to 1,300, which is uncomfortably close to the danger level of 1,000. This month I’m back up to 1,900, so perhaps March was just an outlier.

In other news, the Institute for Clinical and Economic Review has released a report evaluating the tsunami of new multiple myeloma treatments that have been brought to market recently. Three of them received a grade of B+, which sounds pretty good—although it turns out to mean only “moderate certainty of a small net health benefit.” In numbers, that’s an increased survival rate of 5-9 months. And do you remember all those recent news reports about how pricey new cancer treatments are these days? This is now more than an intellectual curiosity for me. These new drugs are really, really expensive: upwards of $400,000 per year of extra life.

And who pays for this? In the narrowest sense, Mother Jones. In a broader sense, everyone who pays premiums to Kaiser Permanente. And in the broadest sense of all, everyone in the country. So you have to decide: is it worth $400,000 to have Kevin Drum around for an extra year? That depends a lot on whether you happen to be Kevin Drum, doesn’t it?

But there’s no need to decide yet. It will likely be years before I need a third-line treatment, and by then maybe something better will be around. Personally, I’m counting on nanobots, so get cracking, nanotechnologists.

TIME IS RUNNING OUT!

We have an ambitious $350,000 online fundraising goal this month and it's truly crunch time: About 15 percent of our yearly online giving usually comes in during the final week of the year, and in "No Cute Headlines or Manipulative BS," we explain why we simply can't afford to come up short right now.

The bottom line: Corporations and powerful people with deep pockets will never sustain the type of journalism Mother Jones exists to do. And advertising or profit-driven ownership groups will never make time-intensive, in-depth reporting viable.

That's why donations big and small make up 74 percent of our budget this year. There is no backup to keep us going, no alternate revenue source, no secret benefactor. If readers don’t donate, we won’t be here. It's that simple.

And if you can help us out with a donation right now, all online gifts will be matched thanks to an incredibly generous matching gift pledge.

payment methods

TIME IS RUNNING OUT!

We have an ambitious $350,000 online fundraising goal this month and it's truly crunch time: About 15 percent of our yearly online giving usually comes in during the final week of the year, and in "No Cute Headlines or Manipulative BS," we explain why we simply can't afford to come up short right now.

The bottom line: Corporations and powerful people with deep pockets will never sustain the type of journalism Mother Jones exists to do. And advertising or profit-driven ownership groups will never make time-intensive, in-depth reporting viable.

That's why donations big and small make up 74 percent of our budget this year. There is no backup to keep us going, no alternate revenue source, no secret benefactor. If readers don’t donate, we won’t be here. It's that simple.

And if you can help us out with a donation right now, all online gifts will be matched thanks to an incredibly generous matching gift pledge.

payment methods

We Recommend

Latest

Sign up for our free newsletter

Subscribe to the Mother Jones Daily to have our top stories delivered directly to your inbox.

Get our award-winning magazine

Save big on a full year of investigations, ideas, and insights.

Subscribe

Support our journalism

Help Mother Jones' reporters dig deep with a tax-deductible donation.

Donate